Status:
TERMINATED
Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Parecoxib
Rib Fractures
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Patients diagnosed traumatic rib fracture and need admission will be included. Patients will be divided two groups.The experimental group will be given parecoxib after visiting emergency department. T...
Detailed Description
3.1 Inclusion/exclusion criteria Patients who are diagnosed ribs fracture and need admission. Exclusion criteria included heart failure, Coronary artery disease (CAD) history. Traumatic cardiac injury...
Eligibility Criteria
Inclusion
- Investigators will prospective enroll patients who are diagnosed chest trauma with rib fractures
- Age ≧18 y/o
Exclusion
- Patients who have history of heart failure, CAD history.
- Traumatic cardiac injury and cardiac tamponade
- History of allergy effect for Cyclooxygenase 2 (COX2) inhibitor or NSAID
Key Trial Info
Start Date :
August 8 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2018
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT02749409
Start Date
August 8 2016
End Date
July 20 2018
Last Update
January 31 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.